GREY:ATBPF - Post Discussion
Post by
Duster340 on Aug 14, 2023 10:11am
No new delays
same timeline for all upcoming milestones. so i think if we get possitive PK/PD study results in the next quarterly report (sep-nov)or the following month (oct-dec calendar Q4) , and the timeline for P2 trial stay's the same antibe should start moving higher. and maybe even earlier if we get some insider buying. we are getting closer, looking forward to the next quarterly report.
Upcoming Milestones
The following summarizes the Company’s estimated timeline for its key upcoming milestones:
- Complete clinical PK/PD study for otenaproxesul – calendar Q4 2023
- Initiate Phase II bunionectomy trial of otenaproxesul – calendar Q1 2024
- Deliver Phase II bunionectomy top-line data of otenaproxesul – calendar Q2 2024
Be the first to comment on this post